title: Different antibiotic regimens for treating asymptomatic bacteriuria in pregnancy.
abstract: BACKGROUND
  Asymptomatic bacteriuria occurs in 5% to 10% of pregnancies and, if left untreated, can lead to serious complications.
  
  
  OBJECTIVE
  To assess which antibiotic is most effective and least harmful as initial treatment for asymptomatic bacteriuria in pregnancy.
  
  
  METHODS
  We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (March 2010) and reference lists of retrieved studies.
  
  
  METHODS
  Randomized controlled trials comparing two antibiotic regimens for treating asymptomatic bacteriuria.
  
  
  METHODS
  Review authors independently screened the studies for inclusion and extracted data.
  
  
  RESULTS
  We included five studies involving 1140 women with asymptomatic bacteriuria. We did not perform meta-analysis; each trial examined different antibiotic regimens and so we were not able to pool results. In a study comparing a single dose of fosfomycin trometamol 3 g with a five-day course of cefuroxime, there was no significant difference in persistent infection (risk ratio (RR) 1.36, 95% confidence interval (CI) 0.24 to 7.75), shift to other antibiotics (RR 0.08, 95% CI 0.00 to 1.45), or in allergy or pruritus (RR 2.73, 95% CI 0.11 to 65.24). A comparison of seven-day courses of 400 mg pivmecillinam versus 500 mg ampicillin, both given four times daily, showed no significant difference in persistent infection at two weeks or recurrent infection, but there was an increase in vomiting (RR 4.57, 95% CI 1.40 to 14.90) and women were more likely to stop treatment early with pivmecillinam (RR 8.82, 95% CI 1.16 to 66.95). When cephalexin 1 g versus Miraxid(R) (pivmecillinam 200 mg and pivampicillin 250 mg) were given twice-daily for three days, there was no significant difference in persistent or recurrent infection. A one- versus seven-day course of nitrofurantoin resulted in more persistent infection with the shorter course (RR 1.76, 95% CI 1.29 to 2.40), but no significant difference in symptomatic infection at two weeks, nausea, or preterm birth. Comparing cycloserine with sulphadimidine, no significant differences in symptomatic, persistent, or recurrent infections were noted.
  
  
  CONCLUSIONS
  We cannot draw any definite conclusion on the most effective and safest antibiotic regimen for the initial treatment of asymptomatic bacteriuria in pregnancy. One study showed advantages with a longer course of nitrofurantoin, and another showed better tolerability with ampicillin compared with pivmecillinam; otherwise, there was no significant difference demonstrated between groups treated with different antibiotics. Given this lack of conclusive evidence, it may be useful for clinicians to consider factors such as cost, local availability and side effects in the selection of the best treatment option.
authors.affiliation: Department of Obstetrics and Gynecology, University of the Philippines College of Medicine-Philippine General Hospital, Taft Avenue, Manila, Philippines, 1000.
authors.forename: Valerie T
authors.initials: VT
authors.lastname: Guinto
authors.forename: Blanca
authors.initials: B
authors.lastname: De Guia
authors.forename: Mario R
authors.initials: MR
authors.lastname: Festin
authors.forename: Therese
authors.initials: T
authors.lastname: Dowswell
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001437:Bacteriuria / Q000188:drug therapy*; D005260:Female; D006801:Humans; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic
chemical_list: D000900:Anti-Bacterial Agents
references.citation: Br Med J (Clin Res Ed). 1987 Jun 20;294(6587):1579-82
references.pmid: 3113538
references.citation: Int Urogynecol J Pelvic Floor Dysfunct. 2007 May;18(5):525-9
references.pmid: 16941068
references.citation: Minerva Ginecol. 1987 Apr;39(4):289-92
references.pmid: 3601207
references.citation: Clin Obstet Gynecol. 1993 Dec;36(4):855-68
references.pmid: 8293587
references.citation: Eur Urol. 1987;13 Suppl 1:108-13
references.pmid: 3552694
references.citation: Antimicrob Agents Chemother. 1985 Apr;27(4):508-10
references.pmid: 4004191
references.citation: J Infect Dis. 1973 Nov;128:Suppl:657-65 p
references.pmid: 4585966
references.citation: Clin Exp Obstet Gynecol. 2007;34(2):85-7
references.pmid: 17629158
references.citation: Obstet Gynecol. 1982 May;59(5):546-9
references.pmid: 7070725
references.citation: Infect Dis Clin North Am. 2003 Jun;17(2):367-94
references.pmid: 12848475
references.citation: Ir J Med Sci. 1969 Jul;8(7):331-7
references.pmid: 5806178
references.citation: Am J Epidemiol. 1989 Feb;129(2):372-9
references.pmid: 2912046
references.citation: Chemotherapy. 1990;36 Suppl 1:50-2
references.pmid: 2085991
references.citation: J Obstet Gynaecol Br Commonw. 1968 Jan;75(1):59-65
references.pmid: 5635245
references.citation: Cochrane Database Syst Rev. 2003;(4):CD002256
references.pmid: 14583949
references.citation: Infection. 1990;18 Suppl 2:S94-7
references.pmid: 2286469
references.citation: Infection. 1979;7(6):290-3
references.pmid: 232697
references.citation: Cochrane Database Syst Rev. 2000;(2):CD000491
references.pmid: 10796207
references.citation: N Engl J Med. 1971 Oct 7;285(15):820-4
references.pmid: 4936826
references.citation: J Antimicrob Chemother. 2000 Aug;46 Suppl A:29-34
references.pmid: 10969049
references.citation: Am J Obstet Gynecol. 1967 Mar 1;97(5):723-38
references.pmid: 5335276
references.citation: J Antimicrob Chemother. 1982 Sep;10(3):239-48
references.pmid: 6923895
references.citation: Best Pract Res Clin Obstet Gynaecol. 2007 Jun;21(3):439-50
references.pmid: 17347050
references.citation: Urol Clin North Am. 2007 Feb;34(1):35-42
references.pmid: 17145359
references.citation: Clin Obstet Gynaecol. 1986 Jun;13(2):397-416
references.pmid: 3524953
references.citation: J Antimicrob Chemother. 1975 Jun;1(2):171-86
references.pmid: 1100589
references.citation: Int J Gynaecol Obstet. 1998 Dec;63 Suppl 1:S91-5
references.pmid: 10075217
references.citation: J Infect Dis. 1969 Jul;120(1):91-103
references.pmid: 5816817
references.citation: Eur Urol. 1987;13 Suppl 1:22-5
references.pmid: 3552699
references.citation: Cochrane Database Syst Rev. 2001;(2):CD000490
references.pmid: 11405965
references.citation: Med J Aust. 1973 Jun 30;1(2):Suppl:44-8
references.pmid: 4580586
references.citation: Obstet Gynecol. 1977 Mar;49(3):262-5
references.pmid: 320525
references.citation: Br J Urol. 1975 Jun;47(3):335-41
references.pmid: 1095107
references.citation: Postgrad Med J. 1970 Oct;:Suppl:69-74
references.pmid: 5488212
references.citation: Am J Obstet Gynecol. 2007 Jun;196(6):524.e1-5
references.pmid: 17547879
references.citation: Obstet Gynecol. 2009 Feb;113(2 Pt 1):339-45
references.pmid: 19155904
references.citation: J Antimicrob Chemother. 1984 Apr;13(4):383-8
references.pmid: 6327600
references.citation: BMJ. 2005 Nov 12;331(7525):1107
references.pmid: 16282407